We are live on ! Find out more
IFX

INFINEON TECH AG ADS(REP1 ORD)
IFX

Delisted

IFX was delisted on the 23rd of April, 2009.

24 hedge funds and large institutions have $97.6M invested in INFINEON TECH AG ADS(REP1 ORD) in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more funds holding

Funds holding: 1924 (+5)

1% more capital invested

Capital invested by funds: $96.5M → $97.6M (+$1.16M)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
8
Closed
Calls
Puts
Net Calls
Net Calls Change

IFX Hedge Fund Activity: Q1 2021 in Review

24 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in INFINEON TECH AG ADS(REP1 ORD) (IFX) for Q1 2021, worth a combined $97.6M — up 1.2% from $96.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new IFX positions and 0 closed out — a net gain of 5 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Gofen & Glossberg, opening a new position worth an estimated $607K. The largest seller was Thompson Investment Management, cutting an estimated $4.54M.

  • 24 institutional investors held INFINEON TECH AG ADS(REP1 ORD) (IFX) as of Q1 2021, up from 19 in Q4 2020.
  • Funds reported $97.6M of INFINEON TECH AG ADS(REP1 ORD) stock for Q1 2021, up 1.2% quarter-over-quarter.
  • 5 funds opened new INFINEON TECH AG ADS(REP1 ORD) positions in Q1 2021 and 0 closed out, a net change of +5 holders.
  • The largest INFINEON TECH AG ADS(REP1 ORD) buyer in Q1 2021 was Gofen & Glossberg, an estimated $607K added.
  • The largest INFINEON TECH AG ADS(REP1 ORD) seller in Q1 2021 was Thompson Investment Management, an estimated $4.54M sold.

Based on aggregated 13F filings for Q1 2021.